Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ASCENDIS PHARMA A/S

(ASND)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Evolution of the average Target Price on ASCENDIS PHARMA A/S
Target Price consensus revisions : last 18 months
Recommendations (Chart) ASCENDIS PHARMA A/S
Analyst Recommendations on ASCENDIS PHARMA A/S
01/13Wedbush Raises Price Target for Ascendis Pharma A/S to $189 From $186 on EU Approval for P..
MT
01/13Wedbush Cuts Ascendis Pharma's PT to $186 From $191 on Skytrofa Contraindication for PWS, ..
MT
01/06Cowen Starts Ascendis Pharma at Market Perform With $136 Price Target
MT
2021Wells Fargo Starts Ascendis Pharma at Overweight With $176 Price Target
MT
2021SVB Leerink Adjusts Ascendis Pharma's Price Target to $190 from $182, Keeps Outperform Rat..
MT
2021Credit Suisse Lowers Ascendis Pharma's PT to $179 from $185, Updates Model with Q3 Actuals..
MT
2021ASCENDIS PHARMA A/S : BofA Securities Downgrades Ascendis Pharma to Neutral From Buy, Lifts Price Target to $169..
MT
More recommendations
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 13
Last Close Price 107,73 €
Average target price 165,96 €
Spread / Average Target 54,1%
High Price Target 189,93 €
Spread / Highest target 76,3%
Low Price Target 119,05 €
Spread / Lowest Target 10,5%
Consensus detail
Consensus revision (last 18 months)